- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.10. | Generative engine optimisation: closing AI gaps, creating market edge | ||
| 14.10. | La Roche-Posay launches global campaign to spotlight the visible and invisible impact of scars | ||
| 14.10. | Inizio announced as headline sponsor for 2026 Communiqué Awards | ||
| 14.10. | Bioxodes appoints Philippe Monteyne as new chairman of the board | ||
| 14.10. | Pre-commercial to launch-ready: four steps to sharpen strategy, execution and impact | ||
| 13.10. | David Weinreich appointed as Merck's head of R&D and CMO for healthcare | ||
| 13.10. | AstraZeneca announces agreement with US government to reduce medicine costs | ||
| 13.10. | Positioning with purpose | ||
| 10.10. | Lilly's Omvoh shows improved outcomes in ulcerative colitis | ||
| 10.10. | Ireland's largest cancer research initiative launches second phase | ||
| 10.10. | Epsilogen appoints Cristina Oliva as chief medical officer | ||
| 10.10. | Setting the direction - how exemplary brand teams brief their agency partners | ||
| 09.10. | MHRA and FDA expand collaboration on AI and medtech regulation | ||
| 09.10. | Lilly appoints former US FDA director Peter Marks to lead infectious disease division | ||
| 09.10. | Speak up to step forward | ||
| 08.10. | Pfizer's Lorviqua recommended by NICE for lung cancer | ||
| 08.10. | Prime welcomes James Karcher to senior leadership team | ||
| 08.10. | Driving launch excellence with agile transformation | ||
| 07.10. | Havas Life London appoints Fran Griffin as Head of Strategy | ||
| 07.10. | New study highlights global overuse of antibiotics for diverticulitis | ||
| 07.10. | The Rashomon Effect | ||
| 06.10. | PMLiVE's T40 - now open for submissions! | ||
| 06.10. | Roche's small cell lung cancer therapy approved by FDA | ||
| 06.10. | Indegene acquires BioPharm to advance AI-driven life sciences marketing | ||
| 06.10. | The impact of US tariffs on healthcare and life sciences multinationals |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .